Abstract
Francesco Saverio Papadia, Ricardo Vitor Cohen, Paolo Bernante, Mirto Foletto
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
10.1056/nejmoa066254 · 2007
Bariatric Surgery Versus Intensive Medical Therapy for Diabetes—5‐Year Outcomes
10.1056/nejmoa1600869 · 2017
Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity
10.1001/jama.2022.9009 · 2022
Long‐Term Mortality After Gastric Bypass Surgery
10.1056/nejmoa066603 · 2007
Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023
2025
ASMBS Updated Position Statement on Insurance Mandated Preoperative Weight Loss Requirements
10.1016/j.soard.2016.04.019 · 2016
Should Presurgical Psychological Evaluations Still Be a Mandated Requirement for Metabolic and Bariatric Surgery? A Critique of the Literature and Thoughts on Future Directions
10.1016/j.soard.2024.08.001 · 2024
10.1037/14035-000
10.1037/14035-000 · 2013
Tirzepatide Once Weekly for the Treatment of Obesity
10.1056/nejmoa2206038 · 2022
Once‐Weekly Semaglutide in Adults With Overweight or Obesity
10.1056/nejmoa2032183 · 2021
Definition and Diagnostic Criteria of Clinical Obesity
10.1016/s2213-8587(24)00316-4 · 2025
10.1002/oby.24352
10.1002/oby.24352
10.1177/20552076251382040
10.1177/20552076251382040
10.1101/2025.03.06.25323524
10.1101/2025.03.06.25323524
RWD166 Real‐World Utilization Pattern of GLP‐1 Receptor Agonists in German Outpatient Care
10.1016/j.jval.2025.09.2916 · 2025
Unresolved referenced work
Kept as external metadata until matched
The Impact of Bias and Stigma on Patient Referral for Metabolic/Bariatric Surgery: An Algerian Experience
10.1007/s11695-025-07882-w · 2025
Comprehensive Outcomes After Roux‐en‐Y Gastric Bypass With a Near‐Complete 15‐Year Follow‐Up
2024
Payor Status Differences in 30‐Day and 1‐Year Outcomes After Primary Laparoscopic Bariatric Surgery
10.1016/j.soard.2025.01.015 · 2025
The Role of Insurance Plan Design in Bariatric Surgery Utilization: A Systematic Review
2023
Association of Insurance Plan Design With Metabolic and Bariatric Surgery Utilization and Outcomes
2024
10.1111/obr.13796
10.1111/obr.13796
10.1093/bjs/znae052
10.1093/bjs/znae052
Life Expectancy After Bariatric Surgery in the Swedish Obese Subjects Study
10.1056/nejmoa2002449 · 2020
Association of Metabolic‐Bariatric Surgery With Long‐Term Survival in Adults With and Without Diabetes: A One‐Stage Meta‐Analysis
10.1016/s0140-6736(21)00591-2 · 2021
Bariatric Metabolic Surgery vs Glucagon‐Like Peptide‐1 Receptor Agonists and Mortality
10.1001/jamanetworkopen.2024.15392 · 2024
Benefits and Risks of Bariatric Surgery in Adults: A Review
10.1001/jama.2020.12567 · 2020
The Psychosocial Burden of Obesity
10.1016/j.ecl.2016.04.016 · 2016
Patient Preferences for Weight Loss Treatments: A Discrete Choice Experiment
2024
International Consensus Position Statement on the Role of Obesity Management Medications in the Context of Metabolic Bariatric Surgery
10.1093/bjs/znae283 · 2024
Unresolved referenced work
Kept as external metadata until matched
A Cost Comparison of GLP‐1 Receptor Agonists and Bariatric Surgery: What Is the Break Even Point?
10.1007/s00464-024-11191-1 · 2024
Cost‐Effectiveness of Endoscopic, Surgical and Pharmacological Obesity Therapies: A Microsimulation and Threshold Analyses
10.1136/gutjnl-2023-330437 · 2023
Discontinuation of Glucagon‐Like Peptide‐1 Receptor Agonists
2024
Discontinuation and Reinitiation of Dual‐Labeled GLP‐1 Receptor Agonists Among US Adults With Overweight or Obesity
10.1001/jamanetworkopen.2024.57349 · 2025
GLP‐1RA in the Real World: 1‐Year Compliance and Outcomes of Semaglutide Use in Patients With or Without Previous History of Bariatric Surgery
2024
Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension
10.1111/dom.14725 · 2022
Weight Regain After Cessation of Medication for Weight Management: Systematic Review and Meta‐Analysis
10.1136/bmj-2025-085304 · 2026
Variation by Race/Ethnicity in the Utilization and Weight Loss Following Metabolic Bariatric Surgery
10.1016/j.soard.2023.06.007 · 2023
10.1111/dom.70012
10.1111/dom.70012 · doi-reference
10.1016/j.soard.2025.01.008
10.1016/j.soard.2025.01.008 · doi-reference
Influence of Referral Type and Sociodemographic Factors on Completion of Bariatric Surgery
10.1016/j.soard.2024.11.002 · doi-reference